Morning vs evening dosing with tamusuosin in benign prostatic hyperplasia with nocturia patients:Multi-center Randomized Control trial
Not Applicable
- Conditions
- Prostate hypertrophy
- Registration Number
- JPRN-UMIN000004140
- Lead Sponsor
- Department of Urology Tohoku University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
prostate surgery any co-existing condition that that may affect micturition, such as neurogenic bladder, bladder neck contracture, urethral stricture, urinary tract infection, bladder cancer, or acute or chronic prostatitis bladder stones acute urinary retension residural urine volume of ≥200ml prostate malignancy; or, a prostatic specific antigen of ≥10ng/ml unless biopsy had ruled out prostatic cancer apparent dimentia patient.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method